NCT04172467View on ClinicalTrials.gov

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

CompletedOBSERVATIONAL
Enrollment

1,086

Participants

Timeline

Start Date

January 28, 2020

Primary Completion Date

April 25, 2020

Study Completion Date

August 3, 2020

Conditions
Secondary Immunodeficiencies (SID)
Interventions
OTHER

non-interventional retrospective epidemiological observational study

non-interventional retrospective epidemiological observational study

Trial Locations (1)

67655

Privatärztliche Praxis; Innere Medizin, Hämatologie, Internistische Onkologie, Kaiserslautern

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Prof. Hartmut Link

UNKNOWN

collaborator

Takeda

INDUSTRY

collaborator

MMF GmbH

INDUSTRY

collaborator

AIO AG Supportivtherapie

OTHER

collaborator

AG Supportive Maßnahmen in der Onkologie

OTHER

lead

AIO-Studien-gGmbH

OTHER